LFCR vs NTRS · rev $75.5M vs P/E 18, rev $2.69B
Lifecore Biomedical Inc. (LFCR) versus Northern Trust Corporation (NTRS) — a side-by-side from cached financials, not a winner call.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
Latest reported NTRS revenue for 2026-06-30 was $2.69B. Net income was $1.32B. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
LFCR currently screens at market cap $207.1M. NTRS currently screens at market cap $32.02B and trailing P/E 18.1.
Not investment advice. Open the LFCR and NTRS stock pages for the full models.
Not investment advice.